General Information of the Compound
Compound ID
CP0498503
Compound Name
4-(6-Methyl-pyridazin-3-yl)-piperazine-1-carboxylic acid (4-isopropyl-phenyl)-amide
    Show/Hide
Structure
Formula
C19H25N5O
Molecular Weight
339.443
Canonical SMILES
CC(C)c1ccc(NC(=O)N2CCN(CC2)c2ccc(C)nn2)cc1
    Show/Hide
InChI
InChI=1S/C19H25N5O/c1-14(2)16-5-7-17(8-6-16)20-19(25)24-12-10-23(11-13-24)18-9-4-15(3)21-22-18/h4-9,14H,10-13H2,1-3H3,(H,20,25)
    Show/Hide
InChIKey
VYMDLBDOCBPZBN-UHFFFAOYSA-N
Physicochemical Property
logP
3.26252
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
61.36
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44396088
ChEMBL ID
CHEMBL425354
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS